These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Inhibition of Inflammation and Bone Erosion by RNA Interference-Mediated Silencing of Heterogeneous Nuclear RNP A2/B1 in Two Experimental Models of Rheumatoid Arthritis. Herman S, Fischer A, Presumey J, Hoffmann M, Koenders MI, Escriou V, Apparailly F, Steiner G. Arthritis Rheumatol; 2015 Sep 15; 67(9):2536-46. PubMed ID: 26017221 [Abstract] [Full Text] [Related]
8. Pristane-induced arthritis in mice. V. Susceptibility to pristane-induced arthritis is determined by the genetic regulation of the T cell repertoire. Wooley PH, Sud S, Whalen JD, Nasser S. Arthritis Rheum; 1998 Nov 15; 41(11):2022-31. PubMed ID: 9811058 [Abstract] [Full Text] [Related]
9. The TNF-alpha transgenic mouse model of inflammatory arthritis. Li P, Schwarz EM. Springer Semin Immunopathol; 2003 Aug 15; 25(1):19-33. PubMed ID: 12904889 [Abstract] [Full Text] [Related]
10. Complete Freund's adjuvant suppresses the development and progression of pristane-induced arthritis in rats. Zheng CL, Hossain MA, Kukita A, Ohki K, Satoh T, Kohashi O. Clin Immunol; 2002 May 15; 103(2):204-9. PubMed ID: 12027426 [Abstract] [Full Text] [Related]
14. Role of TL1A in the pathogenesis of rheumatoid arthritis. Zhang J, Wang X, Fahmi H, Wojcik S, Fikes J, Yu Y, Wu J, Luo H. J Immunol; 2009 Oct 15; 183(8):5350-7. PubMed ID: 19786547 [Abstract] [Full Text] [Related]
15. Optimization of high-throughput autoantibody profiling for the discovery of novel antigenic targets in rheumatoid arthritis. Somers K, Stinissen P, Somers V. Ann N Y Acad Sci; 2009 Sep 15; 1173():92-102. PubMed ID: 19758137 [Abstract] [Full Text] [Related]
16. Autoantigens and immune pathways in rheumatoid arthritis. Corrigall VM, Panayi GS. Crit Rev Immunol; 2002 Sep 15; 22(4):281-93. PubMed ID: 12678429 [Abstract] [Full Text] [Related]
17. Characterization of autoreactive T cells to the autoantigens heterogeneous nuclear ribonucleoprotein A2 (RA33) and filaggrin in patients with rheumatoid arthritis. Fritsch R, Eselböck D, Skriner K, Jahn-Schmid B, Scheinecker C, Bohle B, Tohidast-Akrad M, Hayer S, Neumüller J, Pinol-Roma S, Smolen JS, Steiner G. J Immunol; 2002 Jul 15; 169(2):1068-76. PubMed ID: 12097415 [Abstract] [Full Text] [Related]
18. Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis. Nandakumar KS, Holmdahl R. Arthritis Res Ther; 2006 Jul 15; 8(6):223. PubMed ID: 17254316 [Abstract] [Full Text] [Related]
20. Multiple specificities of autoantibodies against hnRNP A/B proteins in systemic rheumatic diseases and hnRNP L as an associated novel autoantigen. Siapka S, Patrinou-Georgoula M, Vlachoyiannopoulos PG, Guialis A. Autoimmunity; 2007 May 15; 40(3):223-33. PubMed ID: 17453722 [Abstract] [Full Text] [Related] Page: [Next] [New Search]